A
$ Value
$0
Shares
25,000
Price
$0
Filed
Jun 2
Insider
Name
Albers Jeffrey W.
Title
—
CIK
0001638474
Roles
Director
Transaction Details
Transaction Date
2025-05-29
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
25,000
Footnotes
This option represents a right to purchase 25,000 shares of the Issuer's common stock, which will vest and become exercisable in 12 equal monthly installments following May 29, 2025 until such time as the option is 100% vested, subject to the Reporting Person's continuous service with the Issuer at each vesting date.
Filing Info
Albers Jeffrey W.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-10-13 | KYMR | M | $52K |
| 2025-10-13 | KYMR | ▼ | $296K |
| 2025-10-13 | KYMR | M | $0 |
| 2025-07-17 | BPMC | D | — |
| 2025-07-17 | BPMC | U | — |
| 2025-07-17 | BPMC | D | — |
| 2025-07-17 | BPMC | D | — |
| 2025-07-17 | BPMC | D | — |
| 2025-07-17 | BPMC | D | — |
| 2025-07-17 | BPMC | D | — |
Other Insiders at SYRE (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Turtle Cameron
Chief Executive Officer
|
— | $740K | 2026-04-01 |
|
Burrows Scott L
Chief Financial Officer
|
— | $370K | 2026-04-01 |
|
Sloan Sheldon
Chief Medical Officer
|
— | $398K | 2026-04-01 |